Welcome to LookChem.com Sign In|Join Free

CAS

  • or

7377-08-4

Post Buying Request

7377-08-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7377-08-4 Usage

Chemical Properties

white to light orange-brown crystalline powder

Uses

N-(4-aminobenzoyl)-β-Alanine is a metabolite of BX661A, a therapeutic agent used in the treatment of ulcerative colitis, chemotaxis and reactive oxygen species production in polymorphonuclear leukocy ctes. Inhibits lipid peroxidation in large intestinal mucosa after mesenteric ischemia/reperfusion.

Check Digit Verification of cas no

The CAS Registry Mumber 7377-08-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,3,7 and 7 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 7377-08:
(6*7)+(5*3)+(4*7)+(3*7)+(2*0)+(1*8)=114
114 % 10 = 4
So 7377-08-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H12N2O3/c11-8-3-1-7(2-4-8)10(15)12-6-5-9(13)14/h1-4H,5-6,11H2,(H,12,15)(H,13,14)/p-1

7377-08-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (B20213)  N-(4-Aminobenzoyl)-beta-alanine, 98%   

  • 7377-08-4

  • 10g

  • 475.0CNY

  • Detail
  • Alfa Aesar

  • (B20213)  N-(4-Aminobenzoyl)-beta-alanine, 98%   

  • 7377-08-4

  • 50g

  • 1139.0CNY

  • Detail

7377-08-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(4-Aminobenzoyl)-beta-alanine

1.2 Other means of identification

Product number -
Other names 3-[(4-aminobenzoyl)amino]propanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7377-08-4 SDS

7377-08-4Synthetic route

N-(4-nitrobenzoyl)-beta-alanine
59642-21-6

N-(4-nitrobenzoyl)-beta-alanine

N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

Conditions
ConditionsYield
With 1% Pd/C; hydrogen In methanol at 20℃;98%
With palladium 10% on activated carbon; hydrogen In methanol at 20℃; under 750.075 Torr; for 3h; Inert atmosphere;89%
With palladium on activated carbon; hydrogen In methanol at 20℃; under 750.075 Torr; for 3h;75%
4-nitro-benzoyl chloride
122-04-3

4-nitro-benzoyl chloride

N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aq. NaOH solution
2: zinc; acid
View Scheme
Multi-step reaction with 2 steps
1: sodium hydroxide / 2.5 h / 0 - 20 °C
2: hydrogen; palladium 10% on activated carbon / methanol / 3 h / 20 °C / 750.08 Torr / Inert atmosphere
View Scheme
Multi-step reaction with 3 steps
1: sodium hydroxide / water / 3 h / 5 °C
2: hydrogen / water / 20 °C / 760.05 Torr
3: hydrogenchloride / water / 0.17 h / pH 1 - 2
View Scheme
Multi-step reaction with 2 steps
1: sodium hydroxide / 0.5 h / 0 °C
2: palladium on activated carbon; hydrogen / methanol / 3 h / 20 °C / 750.08 Torr
View Scheme
Na(1+)*C10H9N2O5(1-)

Na(1+)*C10H9N2O5(1-)

N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrogen / water / 20 °C / 760.05 Torr
2: hydrogenchloride / water / 0.17 h / pH 1 - 2
View Scheme
Na(1+)*C10H11N2O3(1-)

Na(1+)*C10H11N2O3(1-)

N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

Conditions
ConditionsYield
With hydrogenchloride In water for 0.166667h; pH=1 - 2;
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

phenol
108-95-2

phenol

(E)-3-(4-((4-hydroxyphenyl)diazenyl)benzamido)propanoic acid

(E)-3-(4-((4-hydroxyphenyl)diazenyl)benzamido)propanoic acid

Conditions
ConditionsYield
Stage #1: N-(4-aminobenzoyl)-B-alanine With hydrogenchloride; sodium nitrite In water at 0℃; for 1h;
Stage #2: phenol With sodium carbonate; sodium hydroxide In water at 0℃; pH=8;
97%
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

salicylic acid
69-72-7

salicylic acid

balsalazide

balsalazide

Conditions
ConditionsYield
Stage #1: N-(4-aminobenzoyl)-B-alanine With hydrogenchloride; sodium nitrite In water at 0 - 5℃; for 1h;
Stage #2: salicylic acid With sodium carbonate; sodium hydroxide In water at 0 - 5℃; for 1h;
95%
Stage #1: N-(4-aminobenzoyl)-B-alanine With methanesulfonic acid; sodium nitrite In water at 10 - 12℃; for 0.5h;
Stage #2: salicylic acid With sodium hydroxide; sodium carbonate In water at 7 - 12℃; for 3h;
Stage #3: With hydrogenchloride; water at 60 - 65℃; for 3h; pH=4.0 - 4.5; Product distribution / selectivity;
90%
Stage #1: N-(4-aminobenzoyl)-B-alanine With hydrogenchloride; sodium nitrite In water at 0℃; for 1h;
Stage #2: salicylic acid With sodium carbonate; sodium hydroxide In water at 0℃; pH=8;
85%
Stage #1: N-(4-aminobenzoyl)-B-alanine With sodium nitrite In water at -5 - 0℃; for 1.5h;
Stage #2: salicylic acid With sodium carbonate; sodium hydroxide In water at -5 - 0℃; for 3h; pH=7.5 - 8.5;
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

ethanol
64-17-5

ethanol

C12H16N2O3*ClH

C12H16N2O3*ClH

Conditions
ConditionsYield
With thionyl chloride at 0℃; for 5h; Inert atmosphere; Reflux;93%
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

4-hydroxy-benzoic acid
99-96-7

4-hydroxy-benzoic acid

3-[4-(4-hydroxy-phenyl-azo)-benzoyl-amino]propionic acid

3-[4-(4-hydroxy-phenyl-azo)-benzoyl-amino]propionic acid

Conditions
ConditionsYield
Stage #1: N-(4-aminobenzoyl)-B-alanine With hydrogenchloride In water at 20 - 25℃;
Stage #2: With sodium nitrite In water at -2 - 2℃;
Stage #3: 4-hydroxy-benzoic acid Further stages;
91%
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

acetic anhydride
108-24-7

acetic anhydride

3-(4-acetylamino-benzoylamino)propionic acid
212198-64-6

3-(4-acetylamino-benzoylamino)propionic acid

Conditions
ConditionsYield
With acetic acid In water at 30 - 45℃;90%
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

β-(N,N-diethylamino)propiophenone hydrochloride
884-12-8

β-(N,N-diethylamino)propiophenone hydrochloride

3-[4-(3-oxo-3-phenylpropylamino)benzamido]-propanoic acid

3-[4-(3-oxo-3-phenylpropylamino)benzamido]-propanoic acid

Conditions
ConditionsYield
In water Heating;87%
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

8-formyl-4-methyl-7-hydroxycoumarin
14003-96-4

8-formyl-4-methyl-7-hydroxycoumarin

7-hydroxy-4-methyl-8-(4'-(N-carboxyethylformamido)phenylimino)methyl-2H-1-benzopyran-2-one

7-hydroxy-4-methyl-8-(4'-(N-carboxyethylformamido)phenylimino)methyl-2H-1-benzopyran-2-one

Conditions
ConditionsYield
In ethanol Reflux;85.1%
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

A

3-(4-hydroxybenzamido)propanoic acid
773838-08-7

3-(4-hydroxybenzamido)propanoic acid

B

4-((2-carboxyethyl)carbamoyl)benzenediazonium chloride

4-((2-carboxyethyl)carbamoyl)benzenediazonium chloride

Conditions
ConditionsYield
With hydrogenchloride; nitric acid; sodium nitrite In water at 20℃; for 1h; Reagent/catalyst;A 7%
B 84%
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

A

3-(4-hydroxybenzamido)propanoic acid
773838-08-7

3-(4-hydroxybenzamido)propanoic acid

B

4-((2-carboxyethyl)carbamoyl)benzenediazonium chloride

4-((2-carboxyethyl)carbamoyl)benzenediazonium chloride

C

3-[(4-chlorobenzoyl)amino]propionic acid
440341-75-3

3-[(4-chlorobenzoyl)amino]propionic acid

Conditions
ConditionsYield
With hydrogenchloride; nitric acid; sodium nitrite In water at 20℃; for 1h; Reagent/catalyst;A 10%
B 80%
C 3%
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

1-(4-ethoxy-phenyl)-3-diethylamino-propan-1-one; hydrochloride
101356-82-5

1-(4-ethoxy-phenyl)-3-diethylamino-propan-1-one; hydrochloride

3-{4-[3-(4-ethoxyphenyl)-3-oxopropylamino]-benzamido}propanoic acid

3-{4-[3-(4-ethoxyphenyl)-3-oxopropylamino]-benzamido}propanoic acid

Conditions
ConditionsYield
In water Heating;79%
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

3-Chloropivaloyl chloride
4300-97-4

3-Chloropivaloyl chloride

3-[4-(3-Chloro-2,2-dimethyl-propionylamino)-benzoylamino]-propionic acid

3-[4-(3-Chloro-2,2-dimethyl-propionylamino)-benzoylamino]-propionic acid

Conditions
ConditionsYield
With pyridine In 1,4-dioxane for 1h; Heating;70%
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

3-Diethylamino-1-(4-isopropoxy-phenyl)-propan-1-one; hydrochloride

3-Diethylamino-1-(4-isopropoxy-phenyl)-propan-1-one; hydrochloride

3-{4-[3-oxo-3-(4-propan-2-yloxyphenyl)propylamino]-benzamido}propanoic acid

3-{4-[3-oxo-3-(4-propan-2-yloxyphenyl)propylamino]-benzamido}propanoic acid

Conditions
ConditionsYield
In water Heating;68%
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

4-hydroxy-benzoic acid
99-96-7

4-hydroxy-benzoic acid

2,4-bis[[4[[(2-carboxyethyl)amino]carbonyl]phenyl]azo]-3-[4-[[(2-carboxyethyl)amino]carbonyl]phenyl]phenol

2,4-bis[[4[[(2-carboxyethyl)amino]carbonyl]phenyl]azo]-3-[4-[[(2-carboxyethyl)amino]carbonyl]phenyl]phenol

Conditions
ConditionsYield
Stage #1: N-(4-aminobenzoyl)-B-alanine With hydrogenchloride In water at 20 - 25℃;
Stage #2: With sodium nitrite In water at -2 - 2℃;
Stage #3: 4-hydroxy-benzoic acid Further stages;
36%
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

β-(N,N-diethylamino)-p-chloropropiophenone hyrdochloride
5409-52-9

β-(N,N-diethylamino)-p-chloropropiophenone hyrdochloride

3-{4-[3-(4-chlorophenyl)-3-oxopropylamino]-benzamido}propanoic acid

3-{4-[3-(4-chlorophenyl)-3-oxopropylamino]-benzamido}propanoic acid

Conditions
ConditionsYield
In water Heating;36%
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

salicylic acid
69-72-7

salicylic acid

3-[[4-[[(2-carboxyethyl)amino]carbonyl]phenyl]azo]-2-hydroxybenzoic acid

3-[[4-[[(2-carboxyethyl)amino]carbonyl]phenyl]azo]-2-hydroxybenzoic acid

Conditions
ConditionsYield
Stage #1: N-(4-aminobenzoyl)-B-alanine With hydrogenchloride In water at 20 - 25℃;
Stage #2: With sodium nitrite In water at 0 - 2℃;
Stage #3: salicylic acid Further stages;
7%
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

2,5,6-triamino-3,4-dihydro-4-pyrimidinone
1004-75-7

2,5,6-triamino-3,4-dihydro-4-pyrimidinone

2,3-dibromopropanal
5221-17-0

2,3-dibromopropanal

N-pteroyl-β-alanine
15677-93-7

N-pteroyl-β-alanine

Conditions
ConditionsYield
With sodium dichromate
With iodine
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

3-(hydroxymethyl)benzo[d]oxazol-2(3H)-one
17832-99-4

3-(hydroxymethyl)benzo[d]oxazol-2(3H)-one

N-{4-[(2-oxo-benzooxazol-3-ylmethyl)-amino]-benzoyl}-β-alanine
67726-28-7

N-{4-[(2-oxo-benzooxazol-3-ylmethyl)-amino]-benzoyl}-β-alanine

Conditions
ConditionsYield
In ethanol Heating;
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

3-(Hydroxymethyl)-2-benzoxazolinethione
3161-58-8

3-(Hydroxymethyl)-2-benzoxazolinethione

N-{4-[(2-thioxo-benzooxazol-3-ylmethyl)-amino]-benzoyl}-β-alanine
67726-31-2

N-{4-[(2-thioxo-benzooxazol-3-ylmethyl)-amino]-benzoyl}-β-alanine

Conditions
ConditionsYield
In ethanol Heating;
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

3-hydroxymethyl-3H-benzothiazole-2-thione
3161-57-7

3-hydroxymethyl-3H-benzothiazole-2-thione

N-{4-[(2-thioxo-benzothiazol-3-ylmethyl)-amino]-benzoyl}-β-alanine
67726-34-5

N-{4-[(2-thioxo-benzothiazol-3-ylmethyl)-amino]-benzoyl}-β-alanine

Conditions
ConditionsYield
In ethanol Heating;
2,5-bis-[4-(5-oxo-2-trifluoromethyl-4,5-dihydro-oxazol-4-yl)-phenoxymethyl]-benzoyl chloride

2,5-bis-[4-(5-oxo-2-trifluoromethyl-4,5-dihydro-oxazol-4-yl)-phenoxymethyl]-benzoyl chloride

N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

3-(4-{2,5-bis-[4-(5-oxo-2-trifluoromethyl-4,5-dihydro-oxazol-4-yl)-phenoxymethyl]-benzoylamino}-benzoylamino)-propionic acid

3-(4-{2,5-bis-[4-(5-oxo-2-trifluoromethyl-4,5-dihydro-oxazol-4-yl)-phenoxymethyl]-benzoylamino}-benzoylamino)-propionic acid

Conditions
ConditionsYield
In dichloromethane at 4℃;
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

dimethyl acetylenedicarboxylate
762-42-5

dimethyl acetylenedicarboxylate

C16H18N2O7

C16H18N2O7

Conditions
ConditionsYield
at 5 - 20℃;
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

C16H16N2O6

C16H16N2O6

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 5 - 20 °C
2: 75 percent / Eaton's reagent / 50 °C
View Scheme
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

3-[4-(3,3-Dimethyl-2-oxo-azetidin-1-yl)-benzoylamino]-propionic acid

3-[4-(3,3-Dimethyl-2-oxo-azetidin-1-yl)-benzoylamino]-propionic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 70 percent / pyridine / dioxane / 1 h / Heating
2: 87 percent / sodium carbonate / dimethylformamide / 1 h / 160 °C
View Scheme
5-methylpyrazine-2-carbonyl chloride
50886-34-5

5-methylpyrazine-2-carbonyl chloride

N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

(2R,4'R,8a'R)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]-6'-oxotetrahydro-2'H-spiro[pyrrolidine-2,7'-pyrrole[2,1-b][1,3]thiazine]-4'-carboxylic acid
894786-97-1

(2R,4'R,8a'R)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]-6'-oxotetrahydro-2'H-spiro[pyrrolidine-2,7'-pyrrole[2,1-b][1,3]thiazine]-4'-carboxylic acid

C27H31N7O5S
894787-31-6

C27H31N7O5S

Conditions
ConditionsYield
Multistep reaction.;5.5 mg
naphthalen-1-yl-acetyl chloride
5121-00-6

naphthalen-1-yl-acetyl chloride

N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

{(5S)-1-[(9H-fluoren-9-yl-methoxy)carbonyl]-6-oxo-1,7-diazaspiro[4,5]dec-7-yl}acetic acid
894786-80-2

{(5S)-1-[(9H-fluoren-9-yl-methoxy)carbonyl]-6-oxo-1,7-diazaspiro[4,5]dec-7-yl}acetic acid

N-{3-[(5R)-7-(2-amino-2-oxoethyl)-6-oxo-1,7-diazaspiro[4,5]dec-1-yl]-3-oxopropyl}-4-[(1-naphthylacetyl)amino]benzamide
894787-21-4

N-{3-[(5R)-7-(2-amino-2-oxoethyl)-6-oxo-1,7-diazaspiro[4,5]dec-1-yl]-3-oxopropyl}-4-[(1-naphthylacetyl)amino]benzamide

Conditions
ConditionsYield
Multistep reaction.;3.5 mg
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

Reaxys ID: 19845716

Reaxys ID: 19845716

Reaxys ID: 19845715

Reaxys ID: 19845715

N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

1-adamantyl isocyanate
4411-25-0

1-adamantyl isocyanate

C21H27N3O4

C21H27N3O4

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 60 - 80℃; for 12h;
N-(4-aminobenzoyl)-B-alanine
7377-08-4

N-(4-aminobenzoyl)-B-alanine

salicylic acid
69-72-7

salicylic acid

5-[2-[4',5-bis[(2-carboxyethyl)carbamoyl]biphenyl-2-yl]diazenyl]-2-hydroxybenzoic acid

5-[2-[4',5-bis[(2-carboxyethyl)carbamoyl]biphenyl-2-yl]diazenyl]-2-hydroxybenzoic acid

Conditions
ConditionsYield
Stage #1: N-(4-aminobenzoyl)-B-alanine With hydrogenchloride In water at 20 - 25℃;
Stage #2: With sodium nitrite In water at -2 - 2℃;
Stage #3: salicylic acid Further stages;

7377-08-4Relevant articles and documents

Identification of the subtype-selective Sirt5 inhibitor balsalazide through systematic SAR analysis and rationalization via theoretical investigations

Bracher, Franz,Dietschreit, Johannes C. B.,Ghazy, Ehab,Glas, Carina,Jung, Manfred,Ochsenfeld, Christian,Sippl, Wolfgang,Urban, Lars,W?ssner, Nathalie

, (2020/08/28)

We report here an extensive structure-activity relationship study of balsalazide, which was previously identified in a high-throughput screening as an inhibitor of Sirt5. To get a closer understanding why this compound is able to inhibit Sirt5, we initially performed docking experiments comparing the binding mode of a succinylated peptide as the natural substrate and balsalazide with Sirt5 in the presence of NAD+. Based on the evidence gathered here, we designed and synthesized 13 analogues of balsalazide, in which single functional groups were either deleted or slightly altered to investigate which of them are mandatory for high inhibitory activity. Our study confirms that balsalazide with all its given functional groups is an inhibitor of Sirt5 in the low micromolar concentration range and structural modifications presented in this study did not increase potency. While changes on the N-aroyl-β-alanine side chain eliminated potency, the introduction of a truncated salicylic acid part minimally altered potency. Calculations of the associated reaction paths showed that the inhibition potency is very likely dominated by the stability of the inhibitor-enzyme complex and not the type of inhibition (covalent vs. non-covalent). Further in-vitro characterization in a trypsin coupled assay determined that the tested inhibitors showed no competition towards NAD+ or the synthetic substrate analogue ZKsA. In addition, investigations for subtype selectivity revealed that balsalazide is a subtype-selective Sirt5 inhibitor, and our initial SAR and docking studies pave the way for further optimization.

Sustainable Synthesis of Balsalazide and Sulfasalazine Based on Diazotization with Low Concentrations of Nitrogen Dioxide in Air

Hofmann, Dagmar,Gans, Eva,Krüll, Jasmin,Heinrich, Markus R.

, p. 4042 - 4045 (2017/03/31)

Low concentrations of nitrogen dioxide, which arises as a side product from a range of industrial processes, can effectively be recycled through the diazotization of anilines. The studies reported herein now demonstrate that the removal of nitrogen dioxide from gas streams is even more effective when hydrophilic anilines are used as starting materials. The diazonium salts, which are obtained in this way in up to quantitative yields, can directly be employed in azo coupling reactions, thus opening up an attractive route to the industrially important group of azo compounds.

Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N′-diaryl urea inhibitors of soluble epoxide hydrolase

Anandan, Sampath-Kumar,Gless, Richard D.

scheme or table, p. 2740 - 2744 (2010/07/15)

The impact of various secondary and tertiary pharmacophores on in vitro potency of soluble epoxide hydrolase (sEH) inhibitors based on the unsymmetrical urea scaffold 1 is discussed. N,N′-Diaryl urea inhibitors of soluble epoxide hydrolase exhibit subtle variations in inhibitory potency depending on the secondary pharmacophore but tolerate considerable structural variation in the second linker/tertiary pharmacophore fragment.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7377-08-4